Race and intensity of post-remission therapy in acute myeloid leukemia

Leukemia Research

Volumn 35, Issue 3, 2011, Pages 346-350

  Brady, Anna K ^a   Fu, Alex Z ^a   Earl, Marc ^a   Kalaycio, Matt ^a   Advani, Anjali ^a   Saunthararajah, Yogen ^a   Sobecks, Ronald ^a   Copelan, Edward ^a   Sekeres, Mikkael A ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Acute myeloid leukemia; Health disparities; Survival analysis; Treatment outcomes

Indexed keywords

CYTARABINE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER THERAPY; CAUCASIAN; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEALTH CARE DISPARITY; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEGRO; OVERALL SURVIVAL; POST REMISSION THERAPY; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; THERAPY DELAY;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CYTARABINE; DRUG RESISTANCE, NEOPLASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MITOXANTRONE; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952107741     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.07.020     Document Type: Article

References (24)

1. Bach P.B., Schrag D., Brawley O.W., Galaznik A., Yakren S., Begg C.B. Survival of blacks and whites after a cancer diagnosis. JAMA 2002, 287:2106-2113.
2. Bradley C.J., Given C.W., Roberts C. Disparities in cancer diagnosis and survival. Cancer 2001, 91:178-188.
3. Steyerberg E.W., Earle C.C., Neville B.A., Weeks J.C. Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol 2005, 23:510-517.
4. Hershman D.L., Unger J.M., Barlow W.E., Hutchins L.F., Martino S., Osborne C.K., et al. Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol 2009, 27:2157-2162.
5. Hardy D., Liu C.C., Xia R., Cormier J.N., Chan W., White A., et al. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer 2009, 115:2199-2211.
6. Brookfield K.F., Cheung M.C., Gomez C., Yang R., Nieder A.M., Lee D.J., et al. Survival disparities among African American women with invasive bladder cancer in Florida. Cancer 2009, 115:4196-4209.
7. Wright J.D., Fiorelli J., Schiff P.B., Burke W.M., Kansler A.L., Cohen C.J., et al. Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer 2009, 115:1276-1285.
8. Bhatia S., Sather H.N., Heerema N.A., Trigg M.E., Gaynon P.S., Robison L.L. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002, 100:1957-1964.
9. Wall A.M., Rubnitz J.E. Pharmacogenomic effects on therapy for acute lymphoblastic leukemia in children. Pharmacogenomics J 2003, 3:128-135.
10. SEER Cancer Statistics Review, 1975-2006 2009, National Cancer Institute, Bethesda, MD.
11. Sekeres M.A., Peterson B., Dodge R.K., Mayer R.J., Moore J.O., Lee E.J., et al. Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia. Blood 2004, 103:4036-4042.
12. Cassileth P.A., Lynch E., Hines J.D., Oken M.M., Mazza J.J., Bennett J.M., et al. Varying intensity of postremission therapy in acute myeloid leukemia. Blood 1992, 79:1924-1930.
13. Children's Oncology Group, Aplenc R., Alonzo T.A., Gerbing R.B., Smith F.O., Meshinchi S., et al. Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group. Blood 2006, 108:74-80.
14. Byrd J.C., Mrozek K., Dodge R.K., Carroll A.J., Edwards C.G., Arthur D.C., et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002, 100:4325-4336.
15. Cheson B.D., Bennett J.M., Kopecky K.J., Buchner T., Willman C.L., Estey E.H., et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria. Treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003, 21:4642-4649.
16. Bierenbaum J., Ning Y., Hoffman A., Gojo I., Baer M.R. Black patients with acute myeloid leukemia (AML) are younger and more commonly female, but have a higher incidence of complex karyotypes when compared to whites (abstract 2649). Blood 2009, 114:2649.
17. Mahlknecht U., Dransfeld C.L., Bulut N., Kramer M., Thiede C., Ehninger G., et al. SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival. Leukemia 2009, 23:1929-1932.
18. Rodriguez C.P., Baz R., Jawde R.A., Rybicki L.A., Kalaycio M.E., Advani A., et al. Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia. Leuk Res 2008, 32:413-420.
19. Morris A.M., Billingsley K.G., Hayanga A.J., Matthews B., Baldwin L.M., Birkmeyer J.D. Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst 2008, 100:738-744.
20. Berndt S.I., Carter H.B., Schoenberg M.P., Newschaffer C.J. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol 2007, 25:3589-3595.
21. Bach P.B., Cramer L.D., Warren J.L., Begg C.B. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999, 341:1198-1205.
22. Bickell N.A., Wang J.J., Oluwole S., Schrag D., Godfrey H., Hiotis K., et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 2006, 24:1357-1362.
23. Albain K.S., Unger J.M., Crowley J.J., Coltman C.A., Hershman D.L. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 2009, 101:984-992.
24. Baker K.S., Davies S.M., Majhail N.S., Hassebroek A., Klein J.P., Ballen K.K., et al. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009, 15:1543-1554.